 <h1>Fasigyn Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>tinidazole</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about tinidazole. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Fasigyn.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to tinidazole: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Carcinogenicity has been seen in mice and rats treated chronically with metronidazole, another nitroimidazole agent. Although such data have not been reported for tinidazole, the two drugs are structurally related and have similar biologic effects. Limit use of tinidazole to approved indication only. Avoid chronic use.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, tinidazole (the active ingredient contained in Fasigyn) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking tinidazole:</p><p>
<i>Rare</i>
</p><ul>
<li>Change in consciousness</li>
<li>cough</li>
<li>loss of consciousness</li>
<li>tightness in chest</li>
<li>troubled breathing</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bleeding gums</li>
<li>blood in urine or stools</li>
<li>burning, numbness, tingling, or painful sensations</li>
<li>chest pain</li>
<li>chills</li>
<li>difficulty swallowing</li>
<li>fast, irregular, pounding, or racing heartbeat or pulse</li>
<li>fever</li>
<li>hives, itching, rash</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>lower back or side pain</li>
<li>nausea</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>pinpoint red spots on the skin</li>
<li>reddening of the skin, especially around ears</li>
<li>seizures</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>swelling of eyes, face, or inside of the nose</li>
<li>swollen glands</li>
<li>ulcers</li>
<li>unsteadiness or awkwardness</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>weakness in the arms, hands, legs, or feet</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of tinidazole may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Bitter taste</li>
<li>metallic taste</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>cramps</li>
<li>difficulty having a bowel movement</li>
<li>dizziness</li>
<li>general feeling of discomfort or illness</li>
<li>headache</li>
<li>heartburn</li>
<li>indigestion</li>
<li>loss of appetite</li>
<li>pain or discomfort in the chest, upper stomach, or throat</li>
<li>vomiting</li>
<li>weight loss</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Body aches or pain</li>
<li>coating on tongue</li>
<li>depression</li>
<li>hoarseness</li>
<li>mood or mental changes</li>
<li>runny nose</li>
<li>tender, swollen glands in the neck</li>
<li>voice changes</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Darkened urine</li>
<li>diarrhea</li>
<li>difficulty in moving</li>
<li>feeling of constant movement of self or surroundings</li>
<li>giddiness</li>
<li>lightheadedness</li>
<li>muscle pain or stiffness</li>
<li>pain, swelling, or redness in joints</li>
<li>sensation of spinning</li>
<li>shakiness and unsteady walk</li>
<li>sleepiness</li>
<li>swelling of the mouth</li>
<li>tongue discoloration</li>
<li>trembling, or other problems with muscle control or coordination</li>
<li>trouble sleeping</li>
<li>unable to sleep</li>
<li>white or brownish vaginal discharge</li>
<li>white patches in the mouth or throat or on the tongue</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tinidazole: compounding powder, oral tablet</i></p><h3>General</h3><p>Reported side effects were typically mild, infrequent, and self-limiting.  Gastrointestinal side effects were reported most often.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, dyspepsia/cramps/epigastric discomfort, vomiting, constipation, diarrhea, abdominal pain, flatulence</p>
<p><b>Rare</b> (less than 0.1%): Furry tongue</p>
<p><b>Frequency not reported</b>: Tongue discoloration, stomatitis, dryness of mouth, salivation, oral candidiasis, glossitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Metallic/bitter taste, headache, dizziness, vertigo</p>
<p><b>Rare</b> (less than 0.1%): Coma</p>
<p><b>Frequency not reported</b>: Convulsions, peripheral neuropathy, ataxia, giddiness, drowsiness, burning sensation, paresthesia, hypoesthesia/numbness, sensory disturbances, dysgeusia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Weakness/fatigue/malaise</p>
<p><b>Frequency not reported</b>: Flushing, fever/pyrexia, thirst, Candida overgrowth, fatigue, malaise<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Allergic dermatitis, pruritus</p>
<p><b>Frequency not reported</b>: Urticaria, rash, sweating, angioedema, fixed drug eruption<sup>[Ref]</sup></p><p>In a study involving 450 patients with fixed drug eruptions, 8 patients were found to have this oral drug as the probable causative agent.  The fixed drug eruptions varied as to duration, shape and size, symptoms, number of lesions, and body site(s) affected.  The study did not break these factors down for each individual causative agent.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Anorexia, decreased appetite</p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, dysuria/painful urination, urine abnormality, pelvic pain, vulvovaginal discomfort, vaginal odor, menorrhagia</p>
<p><b>Frequency not reported</b>: Darkened urine/chromaturia, increased vaginal discharge, female genital pruritus, Candida vaginitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Upper respiratory tract infection</p>
<p><b>Rare</b> (less than 0.1%): Bronchospasm, dyspnea, pharyngitis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Rare</b> (less than 0.1%): Confusion, depression</p>
<p><b>Frequency not reported</b>: Insomnia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (less than 0.1%): Reversible thrombocytopenia</p>
<p><b>Frequency not reported</b>: Neutropenia, leukopenia, increased eosinophil count, decreased hemoglobin<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Severe acute hypersensitivity reactions have been reported during initial or subsequent exposure to this drug.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Drug hypersensitivity</p>
<p><b>Postmarketing reports</b>: Severe acute hypersensitivity reactions, hypersensitivity reactions (included urticaria, pruritus, rash, flushing, sweating, dryness of mouth, fever, burning sensation, thirst, salivation, angioedema, Stevens-Johnson syndrome, erythema multiforme)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Hepatic abnormalities (included raised transaminase level), increased AST, increased blood bilirubin<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Increased blood urea<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Palpitations<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Arthralgias, myalgias, arthritis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Tindamax (tinidazole)." Presutti Laboratories Inc, Arlington Heights, IL. </p><p id="ref_4">4. Mahboob A,  Haroon TS "Drugs causing fixed eruptions: a study of 450 cases." Int J Dermatol 37 (1998): 833-8</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Fasigyn (tinidazole)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: amebicides</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Tindamax</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Amebiasis</li>
<li>Bacterial Vaginitis</li>
<li>Giardiasis</li>
<li>Trichomoniasis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tinidazole: compounding powder, oral tablet</i></p><h3>General</h3><p>Reported side effects were typically mild, infrequent, and self-limiting.  Gastrointestinal side effects were reported most often.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, dyspepsia/cramps/epigastric discomfort, vomiting, constipation, diarrhea, abdominal pain, flatulence</p><p><b>Rare</b> (less than 0.1%): Furry tongue</p><p><b>Frequency not reported</b>: Tongue discoloration, stomatitis, dryness of mouth, salivation, oral candidiasis, glossitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Metallic/bitter taste, headache, dizziness, vertigo</p><p><b>Rare</b> (less than 0.1%): Coma</p><p><b>Frequency not reported</b>: Convulsions, peripheral neuropathy, ataxia, giddiness, drowsiness, burning sensation, paresthesia, hypoesthesia/numbness, sensory disturbances, dysgeusia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Weakness/fatigue/malaise</p><p><b>Frequency not reported</b>: Flushing, fever/pyrexia, thirst, Candida overgrowth, fatigue, malaise<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Allergic dermatitis, pruritus</p><p><b>Frequency not reported</b>: Urticaria, rash, sweating, angioedema, fixed drug eruption<sup>[Ref]</sup></p><p>In a study involving 450 patients with fixed drug eruptions, 8 patients were found to have this oral drug as the probable causative agent.  The fixed drug eruptions varied as to duration, shape and size, symptoms, number of lesions, and body site(s) affected.  The study did not break these factors down for each individual causative agent.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Anorexia, decreased appetite</p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, dysuria/painful urination, urine abnormality, pelvic pain, vulvovaginal discomfort, vaginal odor, menorrhagia</p><p><b>Frequency not reported</b>: Darkened urine/chromaturia, increased vaginal discharge, female genital pruritus, Candida vaginitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Upper respiratory tract infection</p><p><b>Rare</b> (less than 0.1%): Bronchospasm, dyspnea, pharyngitis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Rare</b> (less than 0.1%): Confusion, depression</p><p><b>Frequency not reported</b>: Insomnia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (less than 0.1%): Reversible thrombocytopenia</p><p><b>Frequency not reported</b>: Neutropenia, leukopenia, increased eosinophil count, decreased hemoglobin<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Severe acute hypersensitivity reactions have been reported during initial or subsequent exposure to this drug.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Drug hypersensitivity</p><p><b>Postmarketing reports</b>: Severe acute hypersensitivity reactions, hypersensitivity reactions (included urticaria, pruritus, rash, flushing, sweating, dryness of mouth, fever, burning sensation, thirst, salivation, angioedema, Stevens-Johnson syndrome, erythema multiforme)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Hepatic abnormalities (included raised transaminase level), increased AST, increased blood bilirubin<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Increased blood urea<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Palpitations<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Arthralgias, myalgias, arthritis<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Tindamax (tinidazole)." Presutti Laboratories Inc, Arlington Heights, IL. </p><p id="ref_4">4. Mahboob A,  Haroon TS "Drugs causing fixed eruptions: a study of 450 cases." Int J Dermatol 37 (1998): 833-8</p><h2>More about Fasigyn (tinidazole)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: amebicides</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Amebiasis</li>
<li>Bacterial Vaginitis</li>
<li>Giardiasis</li>
<li>Trichomoniasis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>